SCHEMBL7674113

SCHEMBL7674113

CC(C)Oc1ccccc1Oc1sc2ccccc2c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.41
▸ LOXL2 Q9Y4K0 1/20 0.39
▸ MAPT P10636 5/20 0.37
▸ GAA P10253 2/20 0.37
▸ MCL1 Q07820 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ ACACB O00763 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ S1PR1 P21453 1/20 0.35
▸ S1PR3 Q99500 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ CD274 Q9NZQ7 1/20 0.35
▸ F10 P00742 1/20 0.34
▸ GPR3 P46089 1/20 0.34
▸ IRAK4 Q9NWZ3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7671893 0.82 LOXL2 (0.39) ALOX5LOXL2MAPTGAAMCL1
SCHEMBL7661911 0.76 LOXL2 (0.42) LOXL2MAPTGAAMCL1ALDH1A1
SCHEMBL7662088 0.76 L3MBTL1 (0.40) LOXL2MAPTGAAMCL1ALDH1A1
SCHEMBL7666527 0.74 NPC1 (0.43) LOXL2MAPTMCL1ALDH1A1SMN1; SMN2
SCHEMBL7662062 0.72 MAPT (0.55) LOXL2MAPTGAAMCL1ALDH1A1
SCHEMBL7659816 0.72 ESR1 (0.44) LOXL2MAPTGAAMCL1ALDH1A1
SCHEMBL28851801 0.72 ALDH1A1 (0.52) MAPTGAAALDH1A1ACHEIRAK4
SCHEMBL7668527 0.72 TRPA1 (0.45) LOXL2MCL1ALDH1A1F10OGG1
SCHEMBL7670984 0.71 LOXL2 (0.43) LOXL2MAPTGAAMCL1ALDH1A1
SCHEMBL7667320 0.71 LOXL2 (0.43) LOXL2MAPTGAAMCL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 — — US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 — — US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 — — US disclosed
Send feedback